Dan J. Raz

TL;DR: A practical, quantitative-PCR-based assay reliably identified patients with early-stage non-squamous NSCLC at high risk for mortality after surgical resection and improved prognostic accuracy beyond National Comprehensive Cancer Network criteria for stage I high-risk tumours.

TL;DR: Long-term survival with untreated stage I NSCLC is uncommon, and the vast majority of untreated patients die of lung cancer, so treatment with surgical resection or other ablative therapies should not be delayed even in patients with small lung cancers.

TL;DR: In patients with untreated achalasia, dysphagia was the most frequent complaint, but regurgitation and heartburn were frequently present, and a diagnosis of GERD based on the presence of heartburn was highly unreliable; the prevalence, severity, and duration of chest pain did not correlate with the manometric finding of vigorous achalAsia.

TL;DR: Interdisciplinary palliative care in the ambulatory care setting resulted in significant improvements in QOL, symptoms, and distress for NSCLC patients.

TL;DR: The three-gene signature is strongly associated with prognosis in early-stage SCC and positive independent validation suggests its suitability for selecting SCC patients with an increased risk of death who might benefit from adjuvant treatment.